Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone

ישראלהושלםPHASE3

מצבים רפואיים

Hepatocellular Carcinoma (HCC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama, Birmingham, Alabama, United States

  • Mayo Clinic Arizona, Scottsdale, Arizona, United States

  • UC Irvine Medical Center, Orange, California, United States

  • Stanford University School of Medicine, Palo Alto, California, United States

  • University of Florida Shands Hospital, Gainesville, Florida, United States

  • University of Chicago, Chicago, Illinois, United States

  • University of Kansas Cancer Center, Kansas City, Kansas, United States

  • University of Louisville, Louisville, Kentucky, United States

  • Tulane University Health Sciences Center, New Orleans, Louisiana, United States

  • Mercy Medical Center, Inc., Baltimore, Maryland, United States

  • University of Minnesota, Minneapolis, Minnesota, United States

  • Kansas City Research Institute, Kansas City, Missouri, United States

  • Saint Louis University, St Louis, Missouri, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

  • Billings Clinic, Billings, Montana, United States

  • Morristown Medical Center, Morristown, New Jersey, United States

  • St. Joseph's Hospital, Paterson, New Jersey, United States

  • Ohio State University, Columbus, Ohio, United States

  • Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Rhode Island Hospital, Providence, Rhode Island, United States

  • University of Tennessee Medical Center, Knoxville, Tennessee, United States

  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

  • Benaroya Research Institute at Virginia Mason Hospital, Seattle, Washington, United States

  • Site No. 8409, Adelaide, Australia

  • Site No. 8412, Adelaide, Australia

  • Site No. 8403, Brisbane, Australia

  • Site No. 8401, Camperdown, Australia

  • Site No. 8407, Clayton, Australia

  • Site No. 8406, Concord, Australia

  • Site No. 8408, Fitzroy, Australia

  • Site No. 8405, Footscray, Australia

  • Site No. 8414, Heidelberg, Australia

  • Site No. 8411, Melbourne, Australia

  • Site No. 8402, Parkville, Australia

  • Site No. 8415, Perth, Australia

  • Site No. 8413, Sydney, Australia

  • University of Alberta Hospital, Edmonton, Alberta, Canada

  • Juravinski Cancer Centre, Hamilton, Ontario, Canada

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

  • Site 8829, Changchun, China

  • Site No. 8821, Changsha, China

  • Site 8811, Fuzhou, China

  • Site 8820, Fuzhou, China

  • Site No.8816, Guangdong, China

  • Site 8827, Guangzhou, China

  • Site No.8828, Guangzhou, China

  • Site 8832, Hangzhou, China

  • Site No. 8802, Harbin, China

  • Site 8805, Hefei, China

  • Site No. 8808, Hefei, China

  • Site No.8815, Hefei, China

  • Site No. 8801, Nanjing, China

  • Site 8833, Qingdao, China

  • Site 8806, Shanghai, China

  • Site 8822, Shanghai, China

  • Site 8831, Shanghai, China

  • Site No. 8823, Xi'an, China

  • Site No. 8825, Xi'an, China

  • Site No. 9013, Bondy, France

  • Site No. 9005, Bordeaux, France

  • Site No. 9003, Créteil, France

  • Site No. 9006, Lille, France

  • Site 9012, Montpellier, France

  • Site No. 9008, Nantes, France

  • Site No. 9010, Nice, France

  • Site No. 9007, Paris, France

  • Site No. 9014, Paris, France

  • Site No. 9011, Rennes, France

  • Site No. 9001, Strasbourg, France

  • Site No. 9002, Toulouse, France

  • Site No. 9009, Vandœuvre-lès-Nancy, France

  • Site No. 9111, Aachen, Germany

  • Site No. 9113, Bonn, Germany

  • Site No. 9109, Dresden, Germany

  • Site No. 9108, Frankfurt am Main, Germany

  • Site No. 9106, Hamburg, Germany

  • Site No 9105, Hannover, Germany

  • Site No. 9112, Heidelberg, Germany

  • Site No. 9101, Mainz, Germany

  • Site No. 9102, München, Germany

  • Site No. 9104, Tübingen, Germany

  • Site No. 9110, Ulm, Germany

  • Site No. 8601, Hong Kong, Hong Kong

  • Site No. 9707, Afula, Israel

  • Site 9704, Haifa, Israel

  • Site No. 9702, Haifa, Israel

  • Site No. 9705, Jerusalem, Israel

  • Site No. 9703, Ramat Gan, Israel

  • Site No. 9706, Tel Aviv, Israel

  • Site No.9205, Modena, Italy

  • Site No. 9204, Naples, Italy

  • Site No. 9201, Palermo, Italy

  • Site No. 9203, Parma, Italy

  • Auckland City Hospital, Auckland, New Zealand, New Zealand

  • Site No. 8902, Christchurch, New Zealand

  • Site No. 9404, Coimbra, Portugal

  • Site No. 9405, Coimbra, Portugal

  • Site No. 9403, Lisbon, Portugal

  • Site No. 9401, Porto, Portugal

  • Site No. 9402, Porto, Portugal

  • Site 8702, Singapore, Singapore

  • Site 8703, Singapore, Singapore

  • Site No. 8701, Singapore, Singapore

  • Site No. 8208, Ansan, South Korea

  • Site No. 8211, Bucheon-si, South Korea

  • Site No. 8201, Busan, South Korea

  • Site 8216, Daegu, South Korea

  • Site No. 8207, Daegu, South Korea

  • Site No. 8213, Daegu, South Korea

  • Site No. 8220, Daegu, South Korea

  • Site 8224, Goyang, South Korea

  • Site No. 8221, Jinju, South Korea

  • Site No. 8218, Pusan, South Korea

  • Site No. 8222, Seongnam, South Korea

  • Site No. 8219, Seongnam-si, South Korea

  • Site No. 8202, Seoul, South Korea

  • Site No. 8203, Seoul, South Korea

  • Site No. 8205, Seoul, South Korea

  • Site No. 8209, Seoul, South Korea

  • Site No. 8212, Seoul, South Korea

  • Site No. 8215, Seoul, South Korea

  • Site No. 8223, Seoul, South Korea

  • Site No. 8210, Suwon, South Korea

  • Site No. 8217, Ulsan, South Korea

  • Site No. 8305, Kaohsiung City, Taiwan

  • Site No. 8307, Linkou District, Taiwan

  • Site No. 8306, Taichung, Taiwan

  • Site No. 8302, Tainan, Taiwan

  • Site No. 8301, Taipei, Taiwan

  • Site No. 8303, Taipei, Taiwan

  • Site No. 8502, Bangkok, Thailand

  • Site No. 8505, Bangkok, Thailand

  • Site No. 8503, Chiang Mai, Thailand

  • Site No. 8507, Hat Yai, Thailand

  • Site No. 8501, Khon Kaen, Thailand

  • Site No. 8506, Phitsanulok, Thailand

  • Site No. 9501, Birmingham, United Kingdom

  • Site No. 9505, Guildford, United Kingdom

  • Site No. 9503, Leeds, United Kingdom

  • Site No. 9502, London, United Kingdom

  • Site No. 9504, London, United Kingdom

  • Site No. 9506, London, United Kingdom

מובילי המחקר
  • SillaJen Medical

    Study Director

    SillaJen, Inc.